Stocksigma LogoStocksigma Logo

Nectar Lifesciences Board to Consider Q2 Results on 14th Nov'26

Nectar Lifesciences Limited has scheduled a meeting of its Board of Directors on 14th Nov'26. The board will primarily consider, approve, and take on

Nectar Lifesciences Board to Consider Q2 Results on 14th Nov'26

Nectar Lifesciences Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Nectar Lifesciences Board to Consider Q2 Results on 14th Nov'26 Nectar Lifesciences Limited has scheduled a meeting of its Board of Directors on 14th Nov'26. The board will primarily consider, approve, and take on record the company's unaudited financial results for the quarter ended 30th Sep'26, alongside other related business matters, pursuant to SEBI Listing Obligations and Disclosure Requirements Regulations.

Original exchange filing (PDF)

More announcements from Nectar Lifesciences Ltd

All Nectar Lifesciences Ltd announcements